Non-invasive detection of bilirubin concentrations during the first week of life in a low-resource setting along the Thailand-Myanmar border.

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
Germana Bancone, Mary Ellen Gilder, Elsie Win, Gornpan Gornsawun, Paw Khu Moo, Laypaw Archasuksan, Nan San Wai, Sylverine Win, Borimas Hanboonkunupakarn, Francois Nosten, Verena Ilona Carrara, Rose McGready
{"title":"Non-invasive detection of bilirubin concentrations during the first week of life in a low-resource setting along the Thailand-Myanmar border.","authors":"Germana Bancone, Mary Ellen Gilder, Elsie Win, Gornpan Gornsawun, Paw Khu Moo, Laypaw Archasuksan, Nan San Wai, Sylverine Win, Borimas Hanboonkunupakarn, Francois Nosten, Verena Ilona Carrara, Rose McGready","doi":"10.1136/bmjpo-2024-002754","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Neonatal hyperbilirubinaemia (NH) is a common problem worldwide and is a cause of morbidity and mortality especially in low-resource settings.</p><p><strong>Methods: </strong>A study was carried out at Shoklo Malaria Research Unit (SMRU) clinics along the Thailand-Myanmar border to evaluate a non-invasive test for diagnosis of NH in a low-resource setting. Performance of a transcutaneous bilirubinometer Dräger Jaundice Meter JM-105 was assessed against routine capillary serum bilirubin testing (with BR-501 microbilirubinometer) before phototherapy during neonatal care in the first week of life. Results were analysed by direct agreement and by various bilirubin thresholds used in clinical practice. Total serum bilirubin was also measured in cord blood at birth and tested for prediction of hyperbilirubinaemia requiring phototherapy in the first week of life.</p><p><strong>Results: </strong>Between April 2020 and May 2023, 742 neonates born at SMRU facilities were included in the study. A total of 695 neonates provided one to nine capillary blood samples for analysis of serum bilirubin (total 1244 tests) during the first week of life. Performance of transcutaneous bilirubinometer was assessed in 307 neonates who provided 687 paired transcutaneous capillary blood tests. Bilirubin levels were also measured in 738 cord blood samples. Adjusted values of transcutaneous bilirubinometer showed excellent agreement with capillary serum bilirubin concentration (intraclass correlation coefficient=0.923) and high sensitivity (>98%) at all clinical thresholds analysed across 3 years of sampling and multiple users. Concentrations of bilirubin detected in cord blood were not useful in identifying neonates at risk of hyperbilirubinaemia requiring treatment.</p><p><strong>Conclusions: </strong>The transcutaneous bilirubinometer is a reliable tool to screen neonates and identify those needing confirmatory blood testing. Bilirubin concentrations in cord blood are not predictive of hyperbilirubinaemia in neonates.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11440201/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/bmjpo-2024-002754","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Neonatal hyperbilirubinaemia (NH) is a common problem worldwide and is a cause of morbidity and mortality especially in low-resource settings.

Methods: A study was carried out at Shoklo Malaria Research Unit (SMRU) clinics along the Thailand-Myanmar border to evaluate a non-invasive test for diagnosis of NH in a low-resource setting. Performance of a transcutaneous bilirubinometer Dräger Jaundice Meter JM-105 was assessed against routine capillary serum bilirubin testing (with BR-501 microbilirubinometer) before phototherapy during neonatal care in the first week of life. Results were analysed by direct agreement and by various bilirubin thresholds used in clinical practice. Total serum bilirubin was also measured in cord blood at birth and tested for prediction of hyperbilirubinaemia requiring phototherapy in the first week of life.

Results: Between April 2020 and May 2023, 742 neonates born at SMRU facilities were included in the study. A total of 695 neonates provided one to nine capillary blood samples for analysis of serum bilirubin (total 1244 tests) during the first week of life. Performance of transcutaneous bilirubinometer was assessed in 307 neonates who provided 687 paired transcutaneous capillary blood tests. Bilirubin levels were also measured in 738 cord blood samples. Adjusted values of transcutaneous bilirubinometer showed excellent agreement with capillary serum bilirubin concentration (intraclass correlation coefficient=0.923) and high sensitivity (>98%) at all clinical thresholds analysed across 3 years of sampling and multiple users. Concentrations of bilirubin detected in cord blood were not useful in identifying neonates at risk of hyperbilirubinaemia requiring treatment.

Conclusions: The transcutaneous bilirubinometer is a reliable tool to screen neonates and identify those needing confirmatory blood testing. Bilirubin concentrations in cord blood are not predictive of hyperbilirubinaemia in neonates.

在泰缅边境资源匮乏的地区,对婴儿出生第一周的胆红素浓度进行无创检测。
背景:新生儿高胆红素血症(NH新生儿高胆红素血症(NH)是全球普遍存在的问题,也是发病和死亡的原因之一,尤其是在资源匮乏的环境中:在泰缅边境的 Shoklo Malaria Research Unit (SMRU) 诊所开展了一项研究,以评估在低资源环境中诊断 NH 的无创检验。在新生儿出生后第一周的光疗前,评估了经皮胆红素检测仪 Dräger Jaundice Meter JM-105 与常规毛细血管血清胆红素检测(使用 BR-501 微胆红素检测仪)的性能。根据直接一致性和临床实践中使用的各种胆红素阈值对结果进行了分析。此外,还对出生时脐带血中的血清总胆红素进行了检测,以预测出生后第一周是否出现需要光疗的高胆红素血症:结果:2020 年 4 月至 2023 年 5 月期间,共有 742 名在 SMRU 机构出生的新生儿被纳入研究。共有 695 名新生儿在出生后第一周提供了一至九份毛细血管血液样本,用于分析血清胆红素(共 1244 次检测)。对 307 名新生儿的经皮胆红素计性能进行了评估,这些新生儿提供了 687 次成对的经皮毛细血管血液检测。此外,还测量了 738 份脐带血样本中的胆红素水平。经皮胆红素测定仪的调整值与毛细血管血清胆红素浓度显示出极好的一致性(类内相关系数=0.923),在所有临床阈值分析中,灵敏度高(>98%),适用于 3 年采样和多个使用者。脐带血中检测到的胆红素浓度并不能用于识别需要治疗的高胆红素血症风险新生儿:结论:经皮胆红素检测仪是筛查新生儿和识别需要血液确诊检测的新生儿的可靠工具。脐带血中的胆红素浓度不能预测新生儿是否患有高胆红素血症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信